Reported Standalone quarterly numbers for Vaishali Pharma are:Net Sales at Rs 13.16 crore in September 2022 down 33.75% from Rs. 19.86 crore in September 2021.
Quarterly Net Profit at Rs. 1.99 crore in September 2022 up 42.28% from Rs. 1.40 crore in September 2021.
EBITDA stands at Rs. 3.33 crore in September 2022 up 29.07% from Rs. 2.58 crore in September 2021.
Vaishali Pharma EPS has increased to Rs. 1.89 in September 2022 from Rs. 1.33 in September 2021.
Vaishali Pharma shares closed at 101.30 on November 07, 2022 (NSE) and has given 24.60% returns over the last 6 months and 179.06% over the last 12 months.
| Vaishali Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'22 | Jun'22 | Sep'21 | | Net Sales/Income from operations | 13.19 | 9.66 | 19.66 | | Other Operating Income | -0.03 | 0.52 | 0.20 | | Total Income From Operations | 13.16 | 10.18 | 19.86 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 10.85 | 6.31 | 16.76 | | Increase/Decrease in Stocks | -1.66 | 0.23 | -0.32 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.54 | 0.50 | 0.59 | | Depreciation | 0.14 | 0.09 | 0.10 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.84 | 0.93 | 0.62 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.45 | 2.11 | 2.11 | | Other Income | 0.74 | 0.43 | 0.36 | | P/L Before Int., Excpt. Items & Tax | 3.19 | 2.54 | 2.48 | | Interest | 0.53 | 0.53 | 0.61 | | P/L Before Exceptional Items & Tax | 2.66 | 2.01 | 1.87 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 2.66 | 2.01 | 1.87 | | Tax | 0.66 | 0.50 | 0.47 | | P/L After Tax from Ordinary Activities | 1.99 | 1.51 | 1.40 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.99 | 1.51 | 1.40 | | Equity Share Capital | 10.55 | 10.55 | 10.55 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.89 | 1.43 | 1.33 | | Diluted EPS | 1.89 | 1.43 | 1.33 | | EPS After Extra Ordinary | | Basic EPS | 1.89 | 1.43 | 1.33 | | Diluted EPS | 1.89 | 1.43 | 1.33 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|